University of Texas Houston - Division of Rheumatology and Clinical Immunogenetics is a clinical research site located in Houston, Texas, United States 77030.
Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.
University of Texas Houston - Division of Rheumatology and Clinical Immunogenetics has participated in 5 clinical trials with 1 currently active.
Therapeutic areas: Raynaud's Phenomenon Secondary to Systemic Sclerosis, Raynaud Phenomenon Secondary to Systemic Sclerosis, Pulmonary Hypertension.
Sponsors: Civi Biopharma, Inc., Biogen, Scleroderma Research Foundation, Inc..
Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
University of Texas Houston - Division of Rheumatology and Clinical Immunogenetics has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Texas Houston - Division of Rheumatology and Clinical Immunogenetics has 5 clinical trials on record, with 1 currently active. Their work covers Raynaud's Phenomenon Secondary to Systemic Sclerosis, Raynaud Phenomenon Secondary to Systemic Sclerosis, Pulmonary Hypertension.
Yes — University of Texas Houston - Division of Rheumatology and Clinical Immunogenetics holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.